
    
      The study has the aim to evaluate the improvement in CNS symptoms measured by International
      Co-operative Ataxia Rating Scale (ICARS) in patients with AT, during a period of treatment
      with Ery-Dex (dexamethasone sodium phosphate ex vivo encapsulated into human autologous
      erythrocytes).
    
  